these data identify a circRNA-mediated mechanism that coordinates pericyte biology and vascular homeostasis in DR. Induction of cZNF532 or antagonism of miR-29a-3p is an exploitable therapeutic approach for the treatment of DR.
Circular RNA-ZNF532 regulates diabetes-induced retinal pericyte degeneration and vascular dysfunction.